Skip to content

Safety of ibuprofen after major orthopaedic surgeries - the PERISAFE randomized clinical multicentre trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502502-32-00
Enrollment
2904
Registered
2023-03-17
Start date
2023-04-17
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute postoperative pain, Hip and knee arthroplasties

Brief summary

A composite outcome of either death, acute myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, renal failure, major bleeding, re-operation, gastrointestinal ulcer, or readmission within 90 days postoperatively.

Detailed description

Hospital free days within 90 days postoperatively., A composite outcome of ibuprofen related adverse events based on eight-day postoperative diary: pain or discomfort from the epigastrium, reflux, diarrhoea., A composite outcome of opioid related adverse events based on eight-day postoperative diary: nausea, vomiting, constipation, sedation, headache, mood changes, mouth dryness., Health related quality of life questionnaire via EQ-5D-5L after 90 days and one year postoperatively.

Interventions

DRUGIdentical capsule
DRUGIbuprofen 400 mg
DRUGtabletten

Sponsors

Slagelse Hospital, Slagelse Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
A composite outcome of either death, acute myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, renal failure, major bleeding, re-operation, gastrointestinal ulcer, or readmission within 90 days postoperatively.

Secondary

MeasureTime frame
Hospital free days within 90 days postoperatively., A composite outcome of ibuprofen related adverse events based on eight-day postoperative diary: pain or discomfort from the epigastrium, reflux, diarrhoea., A composite outcome of opioid related adverse events based on eight-day postoperative diary: nausea, vomiting, constipation, sedation, headache, mood changes, mouth dryness., Health related quality of life questionnaire via EQ-5D-5L after 90 days and one year postoperatively.

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 1, 2026